SCHEMBL31307264

SCHEMBL31307264

CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ NTSR2 O95665 9/20 0.56
▸ NTSR1 P30989 9/20 0.56
▸ SORT1 Q99523 8/20 0.56
▸ NPY2R P49146 7/20 0.56
▸ NPY4R P50391 7/20 0.56
▸ NPY5R Q15761 7/20 0.56
▸ NPY1R P25929 5/20 0.56
▸ CALCR P30988 1/20 0.53
▸ EPHA2 P29317 1/20 0.53
▸ EP300 Q09472 1/20 0.53
▸ HIF1A Q16665 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31415955 0.87 NTSR1 (0.58) NTSR2NTSR1SORT1NPY2RNPY4R
SCHEMBL30887563 0.86 CALCR (0.68) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30454832 0.86 EPHA2 (0.57) NTSR2NTSR1SORT1EPHA2
SCHEMBL29423344 0.85 NPY2R (0.56) NTSR2NTSR1SORT1NPY2RNPY4R
SCHEMBL29710469 0.85 EPHA2 (0.58) NPY2RNPY4RNPY5RNPY1REPHA2
SCHEMBL30883234 0.84 NPY2R (0.65) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31182542 0.84 NPY2R (0.69) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30584470 0.83 EPHA2 (0.56) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL9807245 0.83 EPHA2 (0.61) NTSR2NTSR1SORT1EPHA2
SCHEMBL30906429 0.83 EPHA2 (0.60) NPY2RNPY4RNPY5RNPY1RCALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025002590-A1 TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS UNIWERSYTET GDÁNSKI (PL) 2025-01-02 — — WO claimed
EP-4484954-A1 MHC CLASS I RESTRICTED IMMUNOPEPTIDE PATTERN FOR GENERATION OF ANTI-NSCLC VACCINES Uniwersytet Gdanski (PL) 2025-01-01 — — EP claimed
WO-2025002590-A1 TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS UNIWERSYTET GDÁNSKI (PL) 2025-01-02 — — WO disclosed
EP-4484954-A1 MHC CLASS I RESTRICTED IMMUNOPEPTIDE PATTERN FOR GENERATION OF ANTI-NSCLC VACCINES Uniwersytet Gdanski (PL) 2025-01-01 — — EP disclosed
EP-4484955-A1 METHOD FOR SCREENING OF EXTRACELLULAR TISSUE PEPTIDES IN MAMMALIAN TISSUE SAMPLES FOR HEALTH STATUS EVALUATION, DISEASE DIAGNOSTICS AND NEOANTIGEN DISCOVERY Uniwersytet Gdanski (PL) 2025-01-01 — — EP disclosed
Send feedback